The Path · Seed

Outcome-focused AI therapy built by neuroscientists and Calm alumni

Amount

$14.3M

Round

Seed

Valuation

—

Announced

May 2026

Investors

Lead investor

Prime Movers Lab

Participating investors

Designer Fund Apolo Anton Ohno Deontay Wilder